New eye device could change how we measure nearsightedness

NCT ID NCT07297810

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new device designed to measure nearsightedness and astigmatism. Researchers will compare its accuracy to standard tools used by eye doctors. Thirty adults aged 18-39 who wear glasses will participate. The goal is to see if the new device works as well as current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
device
What this could lead to
If successful, this could lead to a more convenient or accurate way to measure nearsightedness and astigmatism during eye exams.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The device may not be more accurate than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Essilor International - Ci&T 3

    Créteil, France, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.